eMedicine Specialties > Infectious Diseases > Viral Infections

Echoviruses: Differential Diagnoses & Workup

Author: Larry I Lutwick, MD, Professor of Medicine, State University of New York, Downstate Medical School; Director, Infectious Diseases, Veterans Affairs New York Harbor Health Care System, Brooklyn Campus
Coauthor(s): Syed Hussain, Department of Surgery, Nassau University Medical Center
Contributor Information and Disclosures

Updated: Jun 29, 2006

Differential Diagnoses

Coxsackieviruses
Enteroviruses

Other Problems to Be Considered

Poliovirus infections

Workup

Laboratory Studies

  • Viral isolation through cell culture
    • The opportunity to recover a virus in cell culture is optimized by sampling multiple sites.
    • Late in the course of echoviral illness, clinicians use viral cultures of feces because the lower intestine may be the only site from which the agent is still excreted. Physicians can confirm an etiologic diagnosis by isolating virus from CSF, pericardial fluid, tissue, or blood, depending on the clinical syndrome. Remember that the isolation of an echovirus from the stool does not necessarily signify that a systemic or focal illness is due to that virus because it may be an innocent bystander unrelated to pathology elsewhere.
    • With the identification of a characteristic cytopathic effect in any 3 or 4 appropriately chosen cell lines, the laboratory can report a presumptive diagnosis of echoviral infection within several days.
    • In the future, echoviral strains likely will be characterized by genomic sequencing.
  • Polymerase chain reaction
    • Reverse transcriptase–polymerase chain reaction (RT-PCR) is a rapid, sensitive, and specific method of detecting echoviral RNA in clinical specimens.
    • RT-PCR has detected echoviral RNA from CSF, throat swabs, serum, and stool samples. It also has detected echoviral RNA in endomyocardial biopsy specimens from cases of acute myocarditis and is the standard method for the diagnosis of enteroviral meningitis.
  • Serology
    • The optimal use of antibodies for the diagnosis of echoviral infections involves acute and convalescent sera, which should be run in parallel, if possible. A single high antibody result can be misleading.
    • The microneutralization test is the most widely employed method for the determination of antibodies to echoviruses.
  • CSF analysis
    • In chronic meningoencephalitis in hosts who are agammaglobulinemic and other hosts who are immunocompromised, the CSF exhibits lymphocytic pleocytosis and a higher protein concentration than usually is observed in cases of acute enteroviral aseptic meningitis. Enteroviruses can be recovered repeatedly from the CSF over a period of months to years, usually in high titer.
    • In some cases, the virus is isolated only intermittently from CSF or detected only by polymerase chain reaction (PCR). For unknown reasons, finding the virus in the feces usually is more difficult than finding the virus in the CSF. Clinicians have recovered enteroviruses from many other sites in these patients, including the brain, lung, liver, spleen, kidney, myocardium, pericardial fluid, skeletal muscle, and bone marrow. Some patients have been infected with more than one enterovirus serotype, either concurrently or sequentially.

Imaging Studies

  • Radiography: In myopericarditis, enlargement of the cardiac silhouette on chest radiograph films is present in approximately 50% of cases and may be due to either pericardial effusion or cardiac dilatation.
  • Echocardiography: Echocardiography may confirm the presence of acute ventricular dilatation or a diminished cardiac ejection fraction.

Other Tests

  • Electrocardiography: Patients invariably have electrocardiographic abnormalities. With pericarditis or mild myocarditis, these abnormalities consist of ST-segment elevation or nonspecific ST-segment and T-wave abnormalities. More severe myocardial disease may lead to the development of Q waves, ventricular tachyarrhythmias, and all degrees of heart block.

Histologic Findings

In enteroviral myopericarditis, viruses reach the heart during the viremia that follows replication in the GI or respiratory tract. Experimental studies in a murine model strongly suggest that virus replication occurs in the myocytes. A chronic inflammatory response persists for weeks to months when the replicating virus is no longer present in the heart, and this lingering response is the subject of keen interest. Some investigators consider the late-phase inflammatory response to be due to virus-induced, cytotoxic T-lymphocyte destruction of myocytes. Others postulate the development of a myocardial neoantigen or cross-reactivity between viral and myocardial cell antigens. A variable degree of interstitial fibrosis and evidence of myocyte loss accompany healing.

More on Echoviruses

Overview: Echoviruses
Differential Diagnoses & Workup: Echoviruses
Treatment & Medication: Echoviruses
Follow-up: Echoviruses
References

References

  1. Bell EJ, Grist NR. ECHO viruses, carditis, and acute pleurodynia. Am Heart J. Jul 1971;82(1):133-5. [Medline].

  2. Bultmann BD, Eggers HJ, Galle J. Age dependence of paralysis induced by echovirus type 9 in infant mice. J Infect Dis. Jun 1983;147(6):999-1005. [Medline].

  3. CDC. Outbreak of aseptic meningitis associated with multiple enterovirus serotypes--Romania, 1999. MMWR Morb Mortal Wkly Rep. Jul 28 2000;49(29):669-71. [Medline].

  4. Committee on the ECHO Viruses. Enteric cytopathogenic human orphan (ECHO) viruses. Science. 1955;122:1187-8.

  5. Crennan JM, Van Scoy RE, McKenna CH. Echovirus polymyositis in patients with hypogammaglobulinemia. Failure of high-dose intravenous gammaglobulin therapy and review of the literature. Am J Med. Jul 1986;81(1):35-42. [Medline].

  6. Hadfield MG, Seidlin M, Houff SA. Echovirus meningomyeloencephalitis with administration of intrathecal immunoglobulin. J Neuropathol Exp Neurol. Sep 1985;44(5):520-9. [Medline].

  7. Hall CB, Cherry JD, Hatch MH. The return of Boston exanthem. Echovirus 16 infections in 1974. Am J Dis Child. Mar 1977;131(3):323-6. [Medline].

  8. Haynes RE, Cramblett HG, Kronfol HJ. Echovirus 9 meningoencephalitis in infants and children. JAMA. Jun 2 1969;208(9):1657-60. [Medline].

  9. Kaplan GJ, Clark PS, Bender TR. Echovirus type 30 meningitis and related febrile illness: epidemiologic study of an outbreak in an Eskimo community. Am J Epidemiol. Oct 1970;92(4):257-65. [Medline].

  10. Malcom BS, Eiden JJ, Hendley JO. ECHO virus type 9 meningitis simulating tuberculous meningitis. Pediatrics. Apr 1980;65(4):725-6. [Medline].

  11. Modlin JF, Polk BF, Horton P. Perinatal echovirus infection: risk of transmission during a community outbreak. N Engl J Med. Aug 13 1981;305(7):368-71. [Medline].

  12. Spencer FJ. The devil and William Dabney. An epidemiological postscript. JAMA. Feb 21 1966;195(8):645-8. [Medline].

  13. Wilfert CM, Buckley RH, Mohanakumar T. Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia. N Engl J Med. Jun 30 1977;296(26):1485-9. [Medline].

Further Reading

Keywords

echoviruses, enteroviruses, Enterovirus, Picornaviridae, echovirus viremia, acute aseptic meningitis, encephalitis, viremia rash virus-induced rash, viral respiratory illness, herpangina, epidemic pleurodynia, myopericarditis, meningoencephalitis, viral paralysis, viral paresis, echovirus, echo virus

Contributor Information and Disclosures

Author

Larry I Lutwick, MD, Professor of Medicine, State University of New York, Downstate Medical School; Director, Infectious Diseases, Veterans Affairs New York Harbor Health Care System, Brooklyn Campus
Larry I Lutwick, MD is a member of the following medical societies: American College of Physicians and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

Coauthor(s)

Syed Hussain, Department of Surgery, Nassau University Medical Center
Syed Hussain is a member of the following medical societies: American Medical Student Association/Foundation, Phi Beta Kappa, and Sigma Xi
Disclosure: Nothing to disclose.

Medical Editor

Mark Raymond Wallace, MD, Chief, Clinical Professor, Department of Internal Medicine, Division of Infectious Disease, Naval Medical Center at San Diego
Mark Raymond Wallace, MD is a member of the following medical societies: Infectious Diseases Society of America
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Michael Stuart Bronze, MD, Professor, Stewart G Wolf Chair in Internal Medicine, Department of Medicine, University of Oklahoma Health Science Center
Michael Stuart Bronze, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physician Executives, American College of Physicians, American College of Physicians-American Society of Internal Medicine, American Federation for Clinical Research, American Medical Association, American Society for Microbiology, Association of Professors of Medicine, Association of Program Directors in Internal Medicine, Infectious Diseases Society of America, Oklahoma State Medical Association, and Southern Society for Clinical Investigation
Disclosure: Nothing to disclose.

CME Editor

Eleftherios Mylonakis, MD, Clinical and Research Fellow, Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital
Eleftherios Mylonakis, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Society for Microbiology, and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

Chief Editor

Burke A Cunha, MD, Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital
Burke A Cunha, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.